Company intelligence / Profile preview

Embolx

Sunnyvale/Los Altos, California, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Embolx develops advanced microcatheter systems for super-selective, pressure-directed embolization, enabling targeted delivery of anticancer agents directly into the tumor vasculature while minimizing off-target effects. Their Sniper G3 Balloon Occlusion Microcatheter is the latest product iteration, offering enhanced efficiency, ease of use, and extended shelf life. The company is focused on expanding indications and supporting clinical adoption through physician training and conference participation[1][4].

Therapeutic areas: OncologyMen's Health
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Girlow USA (distribution partnership for South America)

Beyond the preview

Go deeper on Embolx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embolx.

Explore the full profile